No results due, these are being constantly reported and even in today's. #1 May was to submit the final paper to BSI for the CE Mark. That was done in mid-May.
Next main positive will be the CE mark. That said another 3 potential resections added to the 5 out of 20 initially is amazing a great news for pancreatic cancer sufferers.
Still very undervalued and will move up to the minimum broker targets of 40c pretty soon. A distribution deal will just add more to the share price.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 99.5¢ | $44.12K | 44.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 968 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6234 | 1 |
View Market Depth
| Last trade - 15.28pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |